Molnupiravir Oral Capsules

molnupiravir dose  Molnupiravir Generic name: molnupiravir Dosage form: oral capsule Drug class: Miscellaneous antivirals  Molnupiravir The most common adverse reactions reported during treatment and during 14 days after the last dose of

Why am I taking LAGEVRIO? LAGEVRIO contains the active ingredient molnupiravir You are being given LAGEVRIO for the treatment of coronavirus disease  The recommended dose of molnupiravir is 800mg taken orally every 12 hours for 5 days Treatment must not be extended

days after the last dose of molnupiravir Drug Interactions1: No No dosage adjustment is required in patients with renal impairment, and no The probability of ≥30% excess toxicity over controls at 800 mg was estimated at % Conclusions Molnupiravir was safe and well tolerated; a dose of 800 mg